Loading…
Zydus Wellness (ZYDUSWELL)₹469.40−1.56%Packaged Foods
In the Jun 2026 quarter (consolidated), Zydus Wellness reported sales of ₹1,440 Cr, up 66.7% from Jun 2025, and net profit of ₹119 Cr, down 7.0% year on year. For the year to Mar 2026, sales were ₹3,976 Cr and net profit ₹197 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 441 | 404 | 785 | 844 | 495 | 464 | 916 | 864 | 652 | 967 | 1,491 | 1,440 |
| Expenses | 422 | 389 | 619 | 685 | 472 | 446 | 722 | 704 | 626 | 903 | 1,212 | 1,193 |
| Operating Profit | 16.96 | 12.97 | 161 | 155 | 19.94 | 14.95 | 189 | 155 | 22.93 | 60.78 | 269 | 241 |
| OPM % | 3.8% | 3.1% | 21.0% | 18.0% | 4.0% | 3.2% | 21.1% | 18.0% | 3.5% | 6.0% | 18.0% | 17.0% |
| Other Income | 4.01 | 3.01 | 4.01 | 5.01 | 10.02 | 4.01 | 1.01 | 3.01 | −33.06 | −6.02 | 1.01 | 4.01 |
| Interest | 5.99 | 5.99 | 5.99 | 3.99 | 0.99 | 2.99 | 3.99 | 1.99 | 15.99 | 40.95 | 38.98 | 25.99 |
| Depreciation | 6.01 | 6.01 | 6.01 | 5.01 | 5.01 | 5.01 | 13.02 | 11.02 | 25.03 | 56.09 | 55.13 | 57.07 |
| Profit before tax | 8.98 | 3.99 | 154 | 152 | 23.95 | 9.99 | 173 | 145 | −50.88 | −41.94 | 177 | 162 |
| Tax % | 31.0% | 92.0% | 3.0% | 3.0% | 12.0% | 37.0% | 1.0% | 12.0% | 4.0% | −4.0% | 9.0% | 27.0% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 5.02 | 0.00 | 0.00 | 0.00 | −28.11 | −5.02 | 0.00 | 0.00 |
| Net Profit | 6.01 | 0.00 | 150 | 148 | 20.99 | 5.99 | 172 | 128 | −52.94 | −39.95 | 162 | 119 |
| EPS (Rs) | 0.20 | 0.02 | 4.73 | 4.65 | 0.67 | 0.21 | 5.42 | 4.03 | −1.67 | −1.26 | 5.10 | 3.75 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 398 | 432 | 515 | 845 | 1,772 | 1,872 | 2,016 | 2,261 | 2,334 | 2,718 | 3,976 | 4,551 |
| Expenses | 304 | 330 | 386 | 656 | 1,444 | 1,519 | 1,661 | 1,915 | 2,016 | 2,326 | 3,443 | 3,935 |
| Operating Profit | 90.81 | 98.76 | 125 | 184 | 320 | 343 | 344 | 336 | 307 | 379 | 508 | 594 |
| OPM % | 23.0% | 23.0% | 24.0% | 22.0% | 18.1% | 18.0% | 17.0% | 15.0% | 13.0% | 14.1% | 13.0% | 13.1% |
| Other Income | 32.10 | 32.07 | 35.07 | 28.07 | −33.08 | −123 | 10.02 | −5.01 | 0.00 | 20.05 | −34.09 | −34.06 |
| Interest | 0.00 | 0.99 | 1.99 | 29.96 | 140 | 83.97 | 25.99 | 15.98 | 23.98 | 11.99 | 97.95 | 122 |
| Depreciation | 7.01 | 7.01 | 9.02 | 13.02 | 26.03 | 25.04 | 24.03 | 25.05 | 24.05 | 28.04 | 147 | 193 |
| Profit before tax | 117 | 124 | 150 | 171 | 121 | 112 | 305 | 290 | 260 | 358 | 230 | 245 |
| Tax % | 10.0% | 10.0% | 9.0% | 0.0% | −17.0% | −6.0% | −1.0% | −7.0% | −3.0% | 3.0% | 14.0% | — |
| Exceptional items | 0.00 | 1.01 | 3.01 | 7.02 | −39.13 | −132 | 0.00 | −9.04 | −12.06 | 16.05 | −32.11 | −33.13 |
| Net Profit | 105 | 111 | 137 | 171 | 142 | 119 | 309 | 310 | 267 | 347 | 197 | 188 |
| EPS (Rs) | 5.29 | 5.60 | 6.87 | 5.89 | 4.93 | 3.74 | 9.74 | 9.79 | 8.41 | 10.94 | 6.22 | 5.92 |
| Dividend payout % | 25.0% | 23.0% | 23.0% | 17.0% | 20.0% | 27.0% | 10.0% | 10.0% | 12.0% | 11.0% | 19.1% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 39.02 | 39.02 | 38.96 | 38.99 | 58.03 | 58.03 | 64.06 | 63.99 | 64.03 | 64.04 | 64.04 | 63.94 |
| Reserves | 366 | 437 | 516 | 650 | 3,320 | 3,391 | 4,488 | 4,763 | 5,046 | 5,280 | 5,591 | 5,742 |
| Borrowings | 0.00 | 0.00 | 25.01 | 25.06 | 1,571 | 1,523 | 551 | 388 | 298 | 330 | 188 | 3,204 |
| Other Liabilities | 102 | 89.12 | 99.52 | 112 | 501 | 607 | 548 | 462 | 415 | 461 | 585 | 1,155 |
| Total Liabilities | 506 | 567 | 680 | 827 | 5,450 | 5,579 | 5,651 | 5,677 | 5,823 | 6,133 | 6,429 | 10,165 |
| Fixed Assets | 83.88 | 81.78 | 103 | 104 | 4,560 | 4,666 | 4,654 | 4,697 | 4,725 | 4,697 | 5,114 | 8,575 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 9.98 | 3.99 | 3.99 | 11.96 | 12.97 | 9.97 | 14.97 | 22.92 |
| Investments | 0.00 | 93.82 | 29.97 | 148 | 45.92 | 110 | 0.00 | 26.96 | 69.93 | 77.85 | 35.96 | 4.99 |
| Other Assets | 422 | 390 | 548 | 576 | 833 | 799 | 993 | 940 | 1,015 | 1,350 | 1,263 | 1,562 |
| Inventories | 26.05 | 24.04 | 32.06 | 35.05 | 233 | 292 | 366 | 363 | 459 | 469 | 519 | 766 |
| Trade receivables | 1.01 | 3.01 | 4.01 | 9.02 | 96.12 | 118 | 94.19 | 142 | 208 | 283 | 368 | 385 |
| Cash & equivalents | 340 | 306 | 441 | 416 | 165 | 82.38 | 254 | 171 | 38.12 | 241 | 74.33 | 112 |
| Total Assets | 506 | 567 | 680 | 827 | 5,450 | 5,579 | 5,651 | 5,677 | 5,823 | 6,133 | 6,429 | 10,165 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 69.26 | 90.37 | 77.28 | 69.21 | 149 | 260 | 288 | 238 | 92.27 | 247 | 381 | 227 |
| Cash from investing activity | 28.96 | −27.96 | −71.88 | −58.88 | −4,085 | −16.98 | −9.99 | −58.90 | −84.89 | −178 | −207 | −2,879 |
| Cash from financing activity | −26.92 | −57.85 | −5.98 | −1.99 | 4,037 | −259 | −215 | −233 | −138 | −25.91 | −185 | 2,692 |
| Net cash flow | 71.13 | 4.01 | −1.01 | 8.02 | 109 | −18.02 | 60.10 | −56.14 | −132 | 43.10 | −13.03 | 44.06 |
| Capex | 4.01 | 4.01 | 31.02 | 8.02 | 17.02 | 25.02 | 20.04 | 75.07 | 45.03 | 28.03 | 66.07 | 102 |
| Free cash flow | 71.87 | 85.94 | 45.94 | 60.94 | 132 | 235 | 269 | 162 | 46.96 | 220 | 315 | 126 |
| CFO / OP % | 80.0% | 114.0% | 86.0% | 64.0% | 115.0% | 81.0% | 83.0% | 70.0% | 28.0% | 81.0% | 99.0% | 50.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 0 | 2 | 2 | 5 | 41 | 23 | 17 | 25 | 33 | 43 | 48 | 34 |
| Inventory days | 76 | 73 | 127 | 113 | 393 | 168 | 158 | 135 | 146 | 150 | 148 | 178 |
| Days payable | 146 | 191 | 264 | 254 | 662 | 289 | 189 | 136 | 100 | 116 | 122 | 107 |
| Cash conversion cycle | −70 | −117 | −135 | −136 | −228 | −98 | −14 | 24 | 79 | 77 | 74 | 105 |
| Working capital days | −37 | −38 | −57 | −26 | −26 | −7 | −35 | −27 | 17 | 20 | 34 | 48 |
| ROCE % | 31.9% | 26.0% | 22.9% | 22.0% | 7.0% | 6.0% | 6.0% | 6.0% | 6.0% | 5.0% | 6.0% | 5.0% |
For the Jun 2026 quarter, Zydus Wellness reported sales of ₹1,440 Cr, up 66.7% year on year and net profit of ₹119 Cr, down 7.0% year on year. The operating margin was 17.0%.
Zydus Wellness' sales for the year to Mar 2026 were ₹3,976 Cr; over the last twelve months they were ₹4,551 Cr.
Net profit for the year to Mar 2026 was ₹197 Cr, and ₹188 Cr over the last twelve months. Earnings per share over the same trailing period were ₹5.92.
Zydus Wellness reported borrowings of ₹3,204 Cr at Mar 2026, against cash and equivalents of ₹112 Cr.
Cash from operations was ₹227 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹126 Cr.